{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:08:59Z","timestamp":1792084139191,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ijantimicag.2016.11.009","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T14:14:47Z","timestamp":1483625687000},"page":"272-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008\u20132013"],"prefix":"10.1016","volume":"49","author":[{"given":"Chien-Yuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Ming","family":"Tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang-Huei","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jih-Luh","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woei","family":"Tsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwei-Fang","family":"Tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7502-9225","authenticated-orcid":false,"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0010","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1182\/asheducation-2013.1.414","article-title":"Evidence-based approach to treatment of febrile neutropenia in hematologic malignancies","volume":"2013","author":"Gea-Banacloche","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0015","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1470-2045(03)01218-X","article-title":"Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment","volume":"4","author":"Vento","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0020","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cncr.11882","article-title":"Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management","volume":"100","author":"Crawford","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0025","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.6004\/jnccn.2015.0014","article-title":"Management of chemotherapy-induced neutropenia: measuring quality, cost, and value","volume":"13","author":"Dinan","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0030","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/cncr.21847","article-title":"Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients","volume":"106","author":"Kuderer","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0035","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/cncr.20983","article-title":"Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy","volume":"103","author":"Caggiano","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0040","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/bjc.2011.284","article-title":"Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patients","volume":"105","author":"Carmona-Bayonas","year":"2011","journal-title":"Br J Cancer"},{"issue":"Suppl. 4","key":"10.1016\/j.ijantimicag.2016.11.009_bib0045","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1086\/427329","article-title":"Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification","volume":"40","author":"Viscoli","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0050","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/bjh.13816","article-title":"The challenge of antibiotic resistance in haematology patients","volume":"172","author":"Blennow","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0055","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/QCO.0000000000000038","article-title":"Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact","volume":"27","author":"Trecarichi","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0060","first-page":"526","article-title":"Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy","volume":"103","author":"Chen","year":"2004","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0065","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1017\/S0950268809991208","article-title":"Epidemiology of bloodstream infections in patients with hematological malignancies with and without neutropenia","volume":"138","author":"Chen","year":"2010","journal-title":"Epidemiol Infect"},{"issue":"Suppl. 5","key":"10.1016\/j.ijantimicag.2016.11.009_bib0070","doi-asserted-by":"crossref","first-page":"S331","DOI":"10.1093\/cid\/ciu598","article-title":"Invasive Gram-positive bacterial infection in cancer patients","volume":"59","author":"Holland","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 5","key":"10.1016\/j.ijantimicag.2016.11.009_bib0075","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.1093\/cid\/ciu612","article-title":"Antibiotic-resistant Gram-negative bacterial infections in patients with cancer","volume":"59","author":"Perez","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0080","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","article-title":"The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients","volume":"18","author":"Klastersky","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0090","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1086\/513764","article-title":"Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America","volume":"25","author":"Hughes","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0095","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0100","article-title":"Performance standards for antimicrobial disk susceptibility tests; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2015"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0105","article-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2015"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0110","article-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute","year":"2016"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0115","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0120","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1002\/cncr.22705","article-title":"Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer","volume":"109","author":"Ansari","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0125","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/jac\/dkm514","article-title":"Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with hematological malignancies: results of a prospective study on 823 patients at a single institution","volume":"61","author":"Cattaneo","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0130","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/CCO.0b013e328352ead2","article-title":"Predictive factors for poor prognosis febrile neutropenia","volume":"24","author":"Ahn","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0135","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/j.seminoncol.2011.03.013","article-title":"Management of the cancer patient with infection and neutropenia","volume":"38","author":"Rapoport","year":"2011","journal-title":"Semin Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2016.11.009_bib0140","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.ijantimicag.2008.06.017","article-title":"Bloodstream infections in cancer patients with febrile neutropenia","volume":"32","author":"Feld","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0145","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/21505594.2016.1156821","article-title":"Bloodstream infections in neutropenic cancer patients: a practical update","volume":"7","author":"Gustinetti","year":"2016","journal-title":"Virulence"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0150","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s15010-013-0525-9","article-title":"The current spectrum of infection in cancer patients with chemotherapy related neutropenia","volume":"42","author":"Nesher","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0155","doi-asserted-by":"crossref","first-page":"e606","DOI":"10.1016\/S1470-2045(14)70344-4","article-title":"Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteria","volume":"15","author":"Ruhnke","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0160","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1586\/17474086.2015.1060576","article-title":"Tackling antibiotic resistance in febrile neutropenia: current challenges with and recommendations for managing infections with resistant Gram-negative organisms","volume":"8","author":"Nou\u00e9r","year":"2015","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0165","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cmi.2015.12.010","article-title":"Bloodstream infection caused by extensively drug-resistant Acinetobacter baumannii in cancer patients: high mortality associated with delayed treatment rather than with the degree of neutropenia","volume":"22","author":"Freire","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0170","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa044097","article-title":"Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia","volume":"353","author":"Bucaneve","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0175","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/QCO.0b013e32834cf054","article-title":"Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients","volume":"24","author":"Bow","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0180","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1093\/jac\/dku305","article-title":"A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies","volume":"69","author":"Vehreschild","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/1040841X.2013.875515","article-title":"Colonization and infection with extended spectrum \u03b2-lactamase producing Enterobacteriaceae in high-risk patients\u2014review of the literature from a clinical perspective","volume":"42","author":"Biehl","year":"2016","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0190","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.diagmicrobio.2013.02.009","article-title":"Tigecycline activity tested against antimicrobial resistant surveillance subsets of clinical bacteria collected worldwide (2011)","volume":"76","author":"Sader","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0195","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1093\/jac\/dks181","article-title":"Microbiological and clinical characteristics of vancomycin-resistant Enterococcus faecium bacteraemia in Taiwan: implication of sequence type for prognosis","volume":"67","author":"Lu","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/668770","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009\u20132010","volume":"34","author":"Sievert","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0205","first-page":"217","article-title":"Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management","volume":"8","author":"O'Driscoll","year":"2015","journal-title":"Infect Drug Resist"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2016.11.009_bib0210","doi-asserted-by":"crossref","first-page":"i7","DOI":"10.1093\/jac\/dkt022","article-title":"Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007\u201311 study","volume":"68","author":"Zhanel","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2016.11.009_bib0215","series-title":"2016 NHSN patient safety component","author":"US Centers for Disease Control and Prevention","year":"2016"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917300018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917300018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T01:49:24Z","timestamp":1568684964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857917300018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0924857917300018"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.11.009","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008\u20132013","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}